| 翻訳と辞書 |
ICAD Inc.
iCAD Inc. (NASDAQ: ICAD), headquartered in Nashua, New Hampshire,〔("icad, Inc. ... At A Glance" ), ''Forbes''. Retrieved 2011-03-24.〕 is a medical-device manufacturer. Having acquired another device-maker, Xoft, at the end of 2010, iCAD almost immediately faced a case of mistaken consequences in some Xoft test-study patients.
==History==
iCad originally focused on image-analysis products designed to help radiologists and other health-care providers detect cancers early. In 2010, in the face of flagging results and stock performance, it acquired Xoft's Axxent system which delivers radiation therapy directly to cancer sites with minimal radiation exposure to surrounding healthy tissue, according to the company. The system was approved in the U.S. for early-stage breast cancer, endometrial cancer and skin cancer, as well as other varieties where radiation therapy is indicated, the initial report on the acquisition stated.〔Jarzemsky, Matt, ("ICad To Acquire Device Maker Xoft For $13.1M In Cash And Stock" ), ''Dow Jones Newswires'', December 16, 2010 1:58 P.M. ET. Retrieved 2011-03-21.〕 The shield used in the system had been cleared by the Food and Drug Administration (FDA) in June 2009 in an abbreviated process used for devices that are considered equivalent to products already on the market. That process, known as 510(k), takes less time than the procedure used to approve a new device, and it generally does not require tests on humans."〔
抄文引用元・出典: フリー百科事典『 ウィキペディア（Wikipedia）』
■ウィキペディアで「ICAD Inc.」の詳細全文を読む
スポンサード リンク
| 翻訳と辞書 : 翻訳のためのインターネットリソース |
Copyright(C) kotoba.ne.jp 1997-2016. All Rights Reserved.
|
|